New P1 trial • CAR T-Cell Therapy
|
ALK (Anaplastic lymphoma kinase) • BCL2 (B-cell CLL/lymphoma 2) • CD19 (CD19 Molecule) • BCL6 (B-cell CLL/lymphoma 6) • IGH (Immunoglobulin Heavy Locus) • IL18 (Interleukin 18)
|
CD19 expression • BCL6 rearrangement • BCL2 rearrangement
|
huCART19-IL18